CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities
Net income (loss)	$ (808,867)	$ 2,965,338
Income from discontinued operations, net of tax	13,799,642	5,617,194
Loss from continuing operations	(14,608,509)	(2,651,856)
Adjustments to reconcile net loss from continuing operations to cash provided by   (used in) operating activities, net of acquisitions
Stock based compensation expense	249,940	150,514
Depreciation and amortization	140,969	139,413
Gain on sale of assets	(57,402)	(1,424)
Reduction of allowance for bad debt	(13,272)	0
Increase in fair value of derivative warrant liability	3,578,947	1,780,203
Loss (gain) on commodity derivative contracts	(257,516)	721,531
Net cash settlements on commodity derivatives	640	(1,306,344)
Amortization of debt discount and deferred costs	1,770,756	0
Changes in operating assets and liabilities
Accounts receivable and other receivables	(647,503)	564,925
Inventory	(9,316,962)	107,718
Prepaid expenses and other current assets	(697,848)	670,125
Accounts payable	7,807,105	814,872
Accrued expenses	(753,259)	(121,174)
Other assets	(1,300,000)	0
Net cash provided by (used in) operating activities from continuing operations	(14,103,914)	868,503
Cash flows from investing activities
Purchase of fixed assets	(53,936)	(464,039)
Investment in Mobile Refinery assets	(6,426,607)	0
Proceeds from sale of fixed assets	131,689	1,600
Net cash used in investing activities from continuing operations	(6,348,854)	(462,439)
Cash flows from financing activities
Payments on finance leases	(39,101)	(67,382)
Proceeds from exercise of options and warrants to common stock	75,600	1,652,022
Line of credit (payments) proceeds, net	0	(133,446)
Payments on note payable	(1,375,917)	(1,036,581)
Net cash provided by (used in) financing activities from continuing operations	(1,339,418)	414,613
Discontinued operations:
Net cash provided by operating activities	10,114,115	1,320,593
Net cash used in investing activities	(342,573)	(554,940)
Net cash used in financing activities	(59,045)	(54,670)
Net cash provided by discontinued operations	9,712,497	710,983
Net change in cash, cash equivalents and restricted cash	(12,079,689)	1,531,660
Cash, cash equivalents, and restricted cash at beginning of the period	136,626,939	10,995,169
Cash, cash equivalents, and restricted cash at end of period	124,547,250	12,526,829
SUPPLEMENTAL INFORMATION
Cash paid for interest	21,294	236,677
Cash paid for taxes	0	0
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Equity component of the convertible note issuance	78,789,472	0
Exchanges of Series B Preferred Stock into common stock	0	4,397,236
Accretion of discount on Series B and B1 Preferred Stock	0	223,727
Dividends-in-kind accrued on Series B and B1 Preferred Stock	0	(258,138)
Cashless warrant exercise	1,113	0
Accretion of redeemable noncontrolling interest to redemption value	421,399	373,748
Series A Preferred Stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Conversion of Series A, B and B1 Preferred Stock into Common Stock	5	0
Series B Preferred Stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Conversion of Series A, B and B1 Preferred Stock into Common Stock	0	1,978,494
Series B1 Preferred Stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Conversion of Series A, B and B1 Preferred Stock into Common Stock	$ 0	$ 3,256,024